Stay updated on Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page
- CheckyesterdayChange DetectedFooter revision label changed from v3.6.0 to v3.6.2, representing a small page update without altering study details.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRecruitment status updated to No longer looking for participants, indicating no new enrollments. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the revision note moved from v3.5.5 to v3.6.0 with a formatting change for Intervention/Treatment.SummaryDifference0.5%

- Check22 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5. This reflects a small page update and does not modify the study data or how the page functions.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page shows a new revision tag (v3.5.4) replacing the prior version, signaling a minor site update without altering study information.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page’s revision/version indicator at the bottom was updated from v3.5.2 to v3.5.3, reflecting an incremental update to the site itself rather than the underlying clinical trial information.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to study details or page layout are indicated.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.